Trastuzumab-targeted gene delivery to Her2-overexpressing breast cancer cells

Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes

(2015) Li Ying Lim et al.   Nanomedicine-Nanotechnology Biology and Medicine

Gene delivery to Her-2+ breast cancer cells using a two-component delivery system to achieve specificity

(2014) Max Kullberg et al.   Nanomedicine-Nanotechnology Biology and Medicine

Targeting Her-2+ Breast Cancer Cells with Bleomycin Immunoliposomes Linked to LLO

(2012) Max Kullberg et al.   MOLECULAR PHARMACEUTICS

The Conformation of the Poly(ethylene glycol) Chain in Mono-PEGylated Lysozyme and Mono-PEGylated Human Growth Hormone

(2011) Sheetal S. Pai et al.   BIOCONJUGATE CHEMISTRY

The therapeutic potential of TRAIL receptor signalling in cancer cells

(2011) Rosario Yerbes et al.   Clinical & Translational Oncology

Construction of a Star-Shaped Copolymer as a Vector for FGF Receptor-Mediated Gene Delivery In Vitro and In Vivo

(2010) Da Li et al.   BIOMACROMOLECULES

Integrin-targeted nanocomplexes for tumour specific delivery and therapy by systemic administration

(2010) Aristides D. Tagalakis et al.   BIOMATERIALS

Listeriolysin O enhances cytoplasmic delivery by Her-2 targeting liposomes

(2010) Max Kullberg et al.   JOURNAL OF DRUG TARGETING

Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance

(2009) Özgür Sahin et al.   BMC Systems Biology

The biological routes of gene delivery mediated by lipid-based non-viral vectors

(2009) Yan Duan et al.   Expert Opinion on Drug Delivery

Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA

(2009) Swati Koppu et al.   JOURNAL OF CONTROLLED RELEASE

Enhanced gene delivery using disulfide-crosslinked low molecular weight polyethylenimine with listeriolysin o-polyethylenimine disulfide conjugate

(2008) Suna Choi et al.   JOURNAL OF CONTROLLED RELEASE

A two-component drug delivery system using Her-2-targeting thermosensitive liposomes

(2008) Max Kullberg et al.   JOURNAL OF DRUG TARGETING

HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer

(2007) E. Azambuja et al.   ANNALS OF ONCOLOGY